References to the "Company," "Periphas Capital Partnering Corporation," "Periphas," "our," "us" or "we" refer to Periphas Capital Partnering Corporation. The following discussion and analysis of the Company's financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements



This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities Exchange
Act of 1934, as amended (the "Exchange Act"). We have based these
forward-looking statements on our current expectations and projections about
future events. These forward-looking statements are subject to known and unknown
risks, uncertainties and assumptions about us that may cause our actual results,
levels of activity, performance or achievements to be materially different from
any future results, levels of activity, performance or achievements expressed or
implied by such forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as "may," "should," "could,"
"would," "expect," "plan," "anticipate," "believe," "estimate," "continue," or
the negative of such terms or other similar expressions. Such statements
include, but are not limited to, possible business combinations and the
financing thereof, and related matters, as well as all other statements other
than statements of historical fact included in this Form
10-Q.
Factors that might cause or contribute to such a discrepancy include, but are
not limited to, those described in our other Securities and Exchange Commission
("SEC") filings.

Overview

We are a blank check company incorporated in Delaware on September 11, 2020. We were formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the "Partnering Transaction"). We are an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.



Our sponsor is PCPC Holdings, LLC, a Delaware limited liability company (the
"Sponsor"). The registration statement for our Initial Public Offering was
declared effective on December 9, 2020. On December 14, 2020, we consummated our
Initial Public Offering of 14,400,000 CAPS
™
at $25.00 per CAPS
™
, generating gross proceeds of $360.0 million, and incurring offering costs of
approximately $4.0 million (net of reimbursement of offering costs of
approximately $350,000 from the underwriter). On December 14, 2020, the
underwriter exercised the over-allotment option in full, and on December 16,
2020, purchased 2,160,000 additional CAPS
™
(the "Over-Allotment CAPS
™
"), generating additional gross proceeds of $54.0 million, and incurred
additional offering costs of approximately $540,000 in underwriting fees (the
"Over-Allotment").

Simultaneously with the closing of the Initial Public Offering, we consummated
the private placement ("Private Placement") of 224,000 private placement CAPS
™
(the "Private Placement CAPS
™
") at a price of $25.00 per CAPS
™
to the Sponsor, generating proceeds of $5.6 million. Simultaneously with the
closing of the Over-Allotment on December 16, 2020, we consummated the second
closing of the Private Placement, resulting in the purchase of an aggregate of
an additional 21,600 Private Placement CAPS
™
at a price of $25.00 per CAPS
™
by the Sponsor, generating gross proceeds to the Company of $540,000.

Upon the closing of the Initial Public Offering and the Private Placement on
December 14, 2020, $360.0 million ($25.00 per CAPS
™
) of the net proceeds of the sale of the CAPS
™
in the Initial Public Offering and of the Private Placement CAPS
™
in the Private Placement were placed in a trust account ("Trust Account")
located in the United States with Continental Stock Transfer & Trust Company
acting as trustee, and were invested in money market funds meeting the
conditions of paragraphs (d)(2), (d)(3) and (d)(4) of Rule
2a-7
under the Investment Company Act of 1940, as amended (the "Investment Company
Act"), which invest only in direct U.S. government treasury obligations, as
determined by us, until the earlier of: (i) the completion of a Partnering
Transaction and (ii) the distribution of the Trust Account as described below.
Upon the closing of the Over-Allotment on December 16, 2020, additional net
proceeds from the consummation of the Over-Allotment of $54.0 million were
placed in the Trust Account, for a total of $414.0 million held in Trust
Account.

                                       20

--------------------------------------------------------------------------------

Table of Contents


Our management has broad discretion with respect to the specific application of
the net proceeds of our initial public offering (the "Initial Public Offering")
of our securities called CAPS
™
, although substantially all of the net proceeds of the Initial Public Offering
are intended to be generally applied toward completing a Partnering Transaction.
Furthermore, there is no assurance that we will be able to successfully complete
a Partnering Transaction.

We will have until December 14, 2022, (or March 14, 2023, if we have executed a
letter of intent, agreement in principle or definitive agreement for the
Partnering Transaction by December 14, 2022) to complete our initial Partnering
Transaction (the "Partnering Period"). If we do not complete a Partnering
Transaction within this period of time (and stockholders do not approve an
amendment to the certificate of incorporation to extend this date), it will
(i) cease all operations except for the purpose of winding up, (ii) as promptly
as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a
per-share
price, payable in cash, of $25.00, and (iii) as promptly as reasonably possible
following such redemption, subject to the approval of the remaining shareholders
and the board of directors, liquidate and dissolve, subject in the case of
clauses (i) and (iii), to our obligations under Delaware law to provide for
claims of creditors and in all cases subject to the other requirements of
applicable law.

Liquidity and Going Concern

As of March 31, 2022, we had cash of approximately $0.2 million and working capital of approximately $0.1 million.

Our liquidity needs through the Initial Public Offering had been satisfied through a payment of $25,000 from the Sponsor to cover certain offering costs on our behalf in exchange for the issuance of the Founder Shares and the Performance Shares, the loan under the Note from the Sponsor of approximately $148,000 to us, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. We fully repaid the Note on December 15, 2020 and borrowing is no longer available. In addition, in order to finance transaction costs in connection with a Partnering Transaction, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide us Working Capital Loans. As of March 31, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.


In connection with our assessment of going concern considerations in accordance
with Financial Accounting Standard Board's ("FASB") Accounting Standards Update
("ASU")
2014-15,
"Disclosures of Uncertainties about an Entity's Ability to Continue as a Going
Concern," we have until December 14, 2022 (or March 14, 2023, if we execute a
letter of intent, agreement in principle or definitive agreement for the
Partnering Transaction by December 14, 2022) to consummate a Partnering
Transaction. It is uncertain that we will be able to consummate a Partnering
Transaction by this time. If a Partnering Transaction is not consummated by this
date, there will be a mandatory liquidation and subsequent dissolution of the
Company. Management has determined that the liquidity condition and mandatory
liquidation, should a Partnering Transaction not occur, and potential subsequent
dissolution raises substantial doubt about the Company's ability to continue as
a going concern. No adjustments have been made to the carrying amounts of assets
or liabilities should the Company be required to liquidate after December 14,
2022.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of its operations and search for a partner candidate company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Results of Operations

Our entire activity since inception up to our Initial Public Offering was in preparation for our Initial Public Offering in December 2020, and since the consummation of our Initial Public Offering, our activity has been limited to the search for a prospective Partnering Transaction. We will not be generating any operating revenues until the closing and completion of our initial Partnering Transaction.

For the three months ended March 31, 2022, we had a net income of approximately $3.5 million, which consisted of approximately a $3.7 million gain from changes in fair value of derivative warrant liabilities and a gain on investments held in Trust Account of approximately $74,000, partially offset by approximately $160,000 in general and administrative expenses, $60,000 in general and administrative expenses-related party, and approximately $49,000 in franchise tax expense.


                                       21

--------------------------------------------------------------------------------

Table of Contents

For the three months ended March 31, 2021, we had a net income of approximately $7.2 million, which consisted of approximately a $7.4 million gain from changes in fair value of derivative warrant liabilities and a gain on investments held in Trust Account of approximately $6,000, partially offset by approximately $132,000 in general and administrative expenses, approximately $63,000 in general and administrative expenses-related party, and approximately $49,000 in franchise tax expense.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities, other than an agreement to pay Administrative Services Agreement fees to our Sponsor that total $20,000 per month for office space, secretarial and administrative services provided to members of our management team. During each of the three months ended March 31, 2022 and 2021, the Company incurred $60,000 in expenses in connection with such services.

Registration and Stockholder Rights


The holders of the Founder Shares, Performance Shares, Forward Purchase Shares,
Private Placement Warrants and private placement shares underlying Private
Placement CAPS
TM
and private placement CAPS
TM
that may be issued upon conversion of Working Capital Loans (and any shares of
Class A common stock issuable upon the exercise of the Private Placement
Warrants that are part of the Private Placement CAPS
TM
, and CAPS
TM
may be issued upon conversion of Working Capital Loans and upon conversion of
the Founder Shares and the Performance Shares) are entitled to registration
rights pursuant to a registration rights agreement signed upon the effective
date of the Initial Public Offering, requiring the Company to register such
securities for resale. The holders of these securities are entitled to make up
to three demands, excluding short form demands, that we register such
securities. In addition, the holders have certain "piggy-back" registration
rights with respect to registration statements filed subsequent to the
completion of the Partnering Transaction. We will bear the expenses incurred in
connection with the filing of any such registration statements.

Critical Accounting Estimates

This management's discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States ("U.S. GAAP"). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We have identified the following as our critical accounting estimates:

Investments Held in the Trust Account

The Company's portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company's investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company's investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in income on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.


                                       22

--------------------------------------------------------------------------------

Table of Contents

Class A Common Stock Subject to Possible Redemption

We account for our Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480. Class A common stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, shares of Class A common stock are classified as stockholders' equity. Our shares of Class A common stock feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, 16,560,000 shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders' equity section of our condensed balance sheets.

We recognize changes in redemption value immediately as they occur and adjust the carrying value of the Class A common stock subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Effective with the closing of the Initial Public Offering and the over-allotment option, we recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

Net Income Per Common Share

We comply with accounting and disclosure requirements of FASB ASC Topic 260, "Earnings Per Share." We have three classes of shares, which are referred to as Class A common stock, Class B common stock, and Class F common stock. Income and losses are shared pro rata between the three classes of shares. Net income (loss) per common stock is calculated by dividing the net income (loss) by the weighted average shares of common stock outstanding for the respective period.

The calculation of diluted net income (loss) per common share does not consider the effect of the warrants issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of 4,201,400 Class A common stock in the calculation of diluted income (loss) per common share, because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per share for the three months ended March 31, 2022 and 2021. Accretion associated with the redeemable Class A common stock is excluded from earnings per share as the redemption value approximates fair value.

Derivative Warrant Liabilities

We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC 815. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.



We issued 4,140,000 warrants to purchase Class A common stock to investors in
our Initial Public Offering and Over-Allotment (the "Public Warrants") and
issued 61,400 Private Placement Warrants (the "Private Warrants"). All of its
outstanding warrants are recognized as derivative liabilities in accordance with
ASC
815-40.
Accordingly, we recognize the warrant instruments as liabilities at fair value
and adjust the carrying value of the instruments to fair value at each reporting
period until they are exercised. The initial fair value of the Public Warrants
was calculated using an option pricing method and the fair value of the Private
Warrants was calculated using the Black-Scholes Option Pricing Model as of
December 14, 2020.

Subsequently, as of March 31, 2022 and December 31, 2021, the fair value of the Private Warrants was calculated using the Black-Scholes Option Pricing Model, and the fair value of the Public Warrants has been measured based on the listed market price of such warrants. The determination of the fair value of the warrant liability may be subject to change as more current information becomes available and accordingly the actual results could differ significantly.


                                       23

--------------------------------------------------------------------------------

Table of Contents

Derivative warrant liabilities are classified as noncurrent liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Recent Issued Accounting Standards

Our management does not believe that any recently issued, but not yet effective, accounting standards updates, if currently adopted, would have a material effect on the accompanying financial statements.

JOBS Act



The Jumpstart Our Business Startups Act of 2012 (the "JOBS Act") contains
provisions that, among other things, relax certain reporting requirements for
qualifying public companies. We qualify as an "emerging growth company" and
under the JOBS Act are allowed to comply with new or revised accounting
pronouncements based on the effective date for private (not publicly traded)
companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting
standards on the relevant dates on which adoption of such standards is required
for
non-emerging
growth companies. As a result, the financial statements may not be comparable to
companies that comply with new or revised accounting pronouncements as of public
company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an "emerging growth company," we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor's attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor's report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO's compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an "emerging growth company," whichever is earlier.

© Edgar Online, source Glimpses